LUISITO TORREGOSA: Open Payments
NPI 1790441590 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65 in 3 payments from 3 companies in 2025. Trend: 2023 $801 · 2024 $547 · 2025 $65
Food & beverage: $65
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: TRINTELLIX, Qelbree.
Industry payments across MD — which companies pay providers there.
